350347 <common-name>3-[[1-[4-[[2-[(5-carboxy-2-chlorophenyl)diazenyl]-3-oxobutanoyl]amino]-2,5-dimethylanilino]-1,3-dioxobutan-2-yl]diazenyl]-4-chlorobenzoic acid</common-name> <description>3-[[1-[4-[[2-[(5-carboxy-2-chlorophenyl)diazenyl]-3-oxobutanoyl]amino]-2,5-dimethylanilino]-1,3-dioxobutan-2-yl]diazenyl]-4-chlorobenzoic acid has the chemical formula C30H26Cl2N6O8. With an average molecular weight of 669.50 g/mol, 3-[[1-[4-[[2-[(5-carboxy-2-chlorophenyl)diazenyl]-3-oxobutanoyl]amino]-2,5-dimethylanilino]-1,3-dioxobutan-2-yl]diazenyl]-4-chlorobenzoic acid is a heavy molecule.</description> <cas>74351-78-3</cas> <pubchem-id>13981353</pubchem-id> <chemical-formula>C30H26Cl2N6O8</chemical-formula> <weight>669.5</weight> <appearance nil="true"/> <melting-point nil="true"/> <boiling-point nil="true"/> <density nil="true"/> <solubility nil="true"/> <specific-gravity nil="true"/> <flash-point nil="true"/> <vapour-pressure nil="true"/> <route-of-exposure nil="true"/> <target nil="true"/> <mechanism-of-toxicity nil="true"/> <metabolism nil="true"/> <toxicity nil="true"/> <lethaldose nil="true"/> <carcinogenicity nil="true"/> <use-source nil="true"/> <min-risk-level nil="true"/> <health-effects nil="true"/> <symptoms nil="true"/> <treatment nil="true"/> <created-at type="dateTime">2026-08-31T15:21:52Z</created-at> <updated-at type="dateTime">2026-08-31T15:21:52Z</updated-at> <interacting-proteins nil="true"/> <wikipedia nil="true"/> <uniprot-id nil="true"/> <kegg-compound-id nil="true"/> <omim-id nil="true"/> <chebi-id nil="true"/> <biocyc-id nil="true"/> <ctd-id nil="true"/> <stitch-id nil="true"/> <drugbank-id nil="true"/> <pdb-id nil="true"/> <actor-id nil="true"/> <organism nil="true"/> <export type="boolean">true</export> <metabolizing-proteins nil="true"/> <transporting-proteins nil="true"/> <moldb-smiles>CC1=CC(=C(C=C1NC(=O)C(C(=O)C)N=NC2=C(C=CC(=C2)C(=O)O)Cl)C)NC(=O)C(C(=O)C)N=NC3=C(C=CC(=C3)C(=O)O)Cl</moldb-smiles> <moldb-formula>C30H26Cl2N6O8</moldb-formula> <moldb-inchi>InChI=1S/C30H26Cl2N6O8/c1-13-9-22(34-28(42)26(16(4)40)38-36-24-12-18(30(45)46)6-8-20(24)32)14(2)10-21(13)33-27(41)25(15(3)39)37-35-23-11-17(29(43)44)5-7-19(23)31/h5-12,25-26H,1-4H3,(H,33,41)(H,34,42)(H,43,44)(H,45,46)</moldb-inchi> <moldb-inchikey>MFNRAHKNWDJWME-UHFFFAOYSA-N</moldb-inchikey> <moldb-average-mass type="decimal" nil="true"/> <moldb-mono-mass type="decimal">668.1189172</moldb-mono-mass> <origin nil="true"/> <state nil="true"/> <logp>6.2</logp> <hmdb-id nil="true"/> <chembl-id nil="true"/> <chemspider-id nil="true"/> <structure-image-file-name nil="true"/> <structure-image-content-type nil="true"/> <structure-image-file-size type="integer" nil="true"/> <structure-image-updated-at type="dateTime" nil="true"/> <biodb-id nil="true"/> <synthesis-reference nil="true"/> <structure-image-caption nil="true"/> <chemdb-id>CHEM346240</chemdb-id> <dsstox-id nil="true"/> <toxcast-id nil="true"/> <stoff-ident-origin nil="true"/> <stoff-ident-id nil="true"/> <susdat-id nil="true"/> <iupac>3-[[1-[4-[[2-[(5-carboxy-2-chlorophenyl)diazenyl]-3-oxobutanoyl]amino]-2,5-dimethylanilino]-1,3-dioxobutan-2-yl]diazenyl]-4-chlorobenzoic acid</iupac> <moldb-polar-surface-area nil="true"/> <moldb-refractivity nil="true"/> <moldb-polarizability nil="true"/> <moldb-rotatable-bond-count nil="true"/> <moldb-acceptor-count nil="true"/> <moldb-donor-count nil="true"/> <moldb-pka-strongest-acidic nil="true"/> <moldb-pka-strongest-basic nil="true"/> <moldb-physiological-charge nil="true"/> <moldb-number-of-rings nil="true"/> <moldb-alogps-logp nil="true"/> <moldb-alogps-logs nil="true"/> <moldb-alogps-solubility nil="true"/> <kingdom>Organic compounds</kingdom> <superklass>Organic acids and derivatives</superklass> <klass>Carboxylic acids and derivatives</klass> <subklass>Amino acids, peptides, and analogues</subklass> <paper-count type="integer" nil="true"/> <sync-id>CED0300654</sync-id> <structure-inchikey>MFNRAHKNWDJWME-UHFFFAOYSA-N</structure-inchikey> <structure-fingerprint>40002000000000000000000000000000024002000000000000000000000000000000000000000000000000000002000024001000000000000080000000000000000000000000400400000000000000000020002000000000000004000000000000000000010000000000000000100000000000001000000000000000000000400020000040000000000000000000200080000000000000000080000040000000000000002000000000000000084100000800000020000000000000000000000000000000000000000000000140000000000010004200002000000200000000000000008000000000040040800000004400000000000000000000000000000000</structure-fingerprint> <structure-pattern-fingerprint>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</structure-pattern-fingerprint> <structure-pickle type="binary" encoding="base64">776t3gAAAAAQAAAAAwAAAAAAAAAuAAAAMAAAAIABBgBgAAAAAQMGQCgAAAAD BAZAaAAAAAMDAQZAKAAAAAMEBkAoAAAAAwQGQGgAAAADAwEGQCgAAAADBAcA aAAAAAMCAQYAKAAAAAMECAAoAAAAAwIGAGAAAAADAQYAKAAAAAMECAAoAAAA AwIGAGAAAAABAwcAKAAAAAMDBwAoAAAAAwMGQCgAAAADBAZAKAAAAAMEBkBo AAAAAwMBBkBoAAAAAwMBBkAoAAAAAwQGQGgAAAADAwEGACgAAAADBAgAKAAA AAMCCABoAAAAAwEBEQAgAAAAAQYAYAAAAAEDBwBoAAAAAwIBBgAoAAAAAwQI ACgAAAADAgYAYAAAAAMBBgAoAAAAAwQIACgAAAADAgYAYAAAAAEDBwAoAAAA AwMHACgAAAADAwZAKAAAAAMEBkAoAAAAAwQGQGgAAAADAwEGQGgAAAADAwEG QCgAAAADBAZAaAAAAAMDAQYAKAAAAAMECAAoAAAAAwIIAGgAAAADAQERACAA AAABCwABAAECaAwCA2gMAwRoDAQFaAwFBmgMBgcgBwggCAkoAggKAAoLAAsM CAILDQAKDgAODygCDxAgEBFoDBESaAwSE2gMExRoDBQVaAwUFiAWFygCFhgg ERkABBoAAxsgGxwgHB0oAhweAB4fAB8gCAIfIQAeIgAiIygCIyQgJCVoDCUm aAwmJ2gMJyhoDCgpaAwoKiAqKygCKiwgJS0ABgFoDBUQaAwpJGgMQgMAAAAG AQYFBAMCBhESExQVEAYlJicoKSQXBAAAAAAAAAAW </structure-pickle> <structure-indexed-at type="dateTime">2026-09-19T05:48:19Z</structure-indexed-at> </compound>